HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin (2005)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; SILVA, ALFREDO RIBEIRO DA - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS MAMÁRIAS; BIOMARCADORES
- Language: Inglês
- Imprenta:
- Publisher place: Rio de Janeiro
- Date published: 2005
- Source:
- Título do periódico: Jornal Brasileiro de Patologia e Medicina Laboratorial
- ISSN: 1676-2444
- Volume/Número/Paginação/Ano: v. 41, n. 3, p. 45, res. 05.08, 2005
- Conference titles: Congresso Brasileiro de Patologia
-
ABNT
RIBEIRO-SILVA, Alfredo et al. HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin. Jornal Brasileiro de Patologia e Medicina Laboratorial. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 abr. 2024. , 2005 -
APA
Ribeiro-Silva, A., Tiezzi, D. G., Andrade, J. M. de, Tiezzi, M. G., Marana, H. R. C., Zola, F. E., & Sarmento Filho, J. M. (2005). HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin. Jornal Brasileiro de Patologia e Medicina Laboratorial. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Ribeiro-Silva A, Tiezzi DG, Andrade JM de, Tiezzi MG, Marana HRC, Zola FE, Sarmento Filho JM. HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2005 ; 41( 3): 45.[citado 2024 abr. 18 ] -
Vancouver
Ribeiro-Silva A, Tiezzi DG, Andrade JM de, Tiezzi MG, Marana HRC, Zola FE, Sarmento Filho JM. HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2005 ; 41( 3): 45.[citado 2024 abr. 18 ] - HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases with review of the literature
- HER2 overexpression predicts survival in stage II and III of breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases and review of the literature
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases
- Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer
- Apoptosis induced by neodjuvant chemotherapy in breast cancer
- Tumor infiltrating lymphocytes are related to lymph node metastasis in patients with T1-T2 breast cancer
- Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer
- Tumor infiltrating lymphocytes are related to lymph node metastasis in patients with T1-T2 breast cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
